Drug intelligence / Profile preview

JOINTUP2

Development stage: Unknown
Lead developer: Biotics Life
Modality: Small Molecules
Administration: Oral

Overview

JOINTUP2 is a multi-ingredient dietary supplement developed and marketed by Biotics Life (Biotics Lab Life Services Pvt Ltd) for the support of joint health and the management of symptoms associated with joint pain and arthritis. Part of the company's Phytoactives product line, JOINTUP2 is formulated with plant-derived compounds intended to provide anti-inflammatory benefits and support the maintenance of joint cartilage. The product is sold as an over-the-counter (OTC) nutraceutical and is typically administered orally in capsule form. It is marketed primarily to consumers seeking natural alternatives for mobility support and joint comfort.

Brand names: JOINTUP2JOINTUP-2JOINTUP 2

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)CD44 (CD44 antigen)VDR (Vitamin D receptor)

Beyond the preview

Go deeper on JOINTUP2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on JOINTUP2.

Explore the full profile